The Mark Foundation for Cancer Research has awarded six new Emerging Leader Awards.
Share: email Subscribe
Weekly Top Stories Tue, 24 Jan 2023
We have 30 articles this week. #Advaxis and # Ayala Pharmaceuticals Complete Merger. #Avail Scientific Signs LOI to Acquire #Florida Neurological Testing Company #Relai Neuro. #Tigermed Completes Acquisition of #Marti Farm. #bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock. #Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure, and $250,000 of Funding by the #McGill University Health Centre Foundation. #Endevica Bio Raises $10 Million in Series B Financing to Advance Development of TCMCB07 for Treatment of #Cachexia. # Jazz’s $375M Investment in #Zymeworks Paying Off in GI Cancer. #SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases. #Albertsons to pay $6.85 a share special dividend on Friday. #Intermountain and #Story Health Partner on Specialty Care for Patients with Heart Failure
Editor's Choice
1. 
The Mark Foundation for Cancer Research Announces 2023 Emerging Leader Awards
2. 
Editas Makes Good on Portfolio Reprioritization with Shoreline Deals
3. 
Inflation, Recession Fears Increase Tension Between Healthcare Patients and Providers
4. 
Orbita Launches Blaze to Convert Websites into Virtual Assistant
5. 
AVIA Launches Nationwide Digital Health Marketplace
Top 09 M&A Transactions
6. 
Advaxis and Ayala Pharmaceuticals Complete Merger
7. 
Avail Scientific Signs LOI to Acquire Florida Neurological Testing Company Relai Neuro
8. 
Tigermed Completes Acquisition of Marti Farm
9. 
bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock
10. 
Endevica Bio Raises $10 Million in Series B Financing to Advance Development of TCMCB07 for Treatment of Cachexia
11. 
Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
12. 
8 Executive Pharmacy Predictions/Trends to Watch in 2023
13. 
INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING
14. 
Avulux and Axon Optics join forces, offering the world’s only lens clinically proven to block harmful light linked to migraine attacks
Top 4 Venture Funding
15. 
Jazz’s $375M Investment in Zymeworks Paying Off in GI Cancer
16. 
SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases
17. 
Caris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer Care
18. 
Shockwave Acquires Neovasc in $100M Deal
Top 4 Partnerships Announcements
19. 
Albertsons to pay $6.85 a share special dividend on Friday
20. 
Intermountain and Story Health Partner on Specialty Care for Patients with Heart Failure
21. 
Repare Therapeutics Receives $1.5 Million (¥200 million) Payment from Ono Pharmaceuticals
22. 
Included Health Partners to Deliver First-of-its-Kind LGBTQ+ Health Plan
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us